Endocannabinoids prevent β-amyloid-mediated lysosomal destabilization in cultured neurons

Janis Noonan, Riffat Tanveer, Allan Klompas, Aoife Gowran, Joanne McKiernan, Veronica A. Campbell

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Neuronal cell loss underlies the pathological decline in cognition and memory associated with Alzheimer disease (AD). Recently, targeting the endocannabinoid system in AD has emerged as a promising new approach to treatment. Studies have identified neuroprotective roles for endocannabinoids against key pathological events in the AD brain, including cell death by apoptosis. Elucidation of the apoptotic pathway evoked by β-amyloid (Aβ) is thus important for the development of therapeutic strategies that can thwart Aβ toxicity and preserve cell viability. We have previously reported that lysosomal membrane permeabilization plays a distinct role in the apoptotic pathway initiated by Aβ. In the present study, we provide evidence that the endocannabinoid system can stabilize lysosomes against Aβ-induced permeabilization and in turn sustain cell survival. We report that endocannabinoids stabilize lysosomes by preventing the Aβ-induced up-regulation of the tumor suppressor protein, p53, and its interaction with the lysosomal membrane. We also provide evidence that intracellular cannabinoid type 1 receptors play a role in stabilizing lysosomes against Aβ toxicity and thus highlight the functionality of these receptors. Given the deleterious effect of lysosomal membrane permeabilization on cell viability, stabilization of lysosomes with endocannabinoids may represent a novel mechanism by which these lipid modulators confer neuroprotection.

Original languageEnglish
Pages (from-to)38543-38554
Number of pages12
JournalJournal of Biological Chemistry
Volume285
Issue number49
DOIs
Publication statusPublished - Dec 3 2010

Fingerprint

Endocannabinoids
Amyloid
Neurons
Lysosomes
Cell Survival
Alzheimer Disease
Cells
Membranes
Toxicity
Tumor Suppressor Protein p53
Cannabinoid Receptors
Cannabinoids
Cell death
Cognition
Modulators
Brain
Cell Death
Up-Regulation
Stabilization
Apoptosis

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Endocannabinoids prevent β-amyloid-mediated lysosomal destabilization in cultured neurons. / Noonan, Janis; Tanveer, Riffat; Klompas, Allan; Gowran, Aoife; McKiernan, Joanne; Campbell, Veronica A.

In: Journal of Biological Chemistry, Vol. 285, No. 49, 03.12.2010, p. 38543-38554.

Research output: Contribution to journalArticle

Noonan, Janis ; Tanveer, Riffat ; Klompas, Allan ; Gowran, Aoife ; McKiernan, Joanne ; Campbell, Veronica A. / Endocannabinoids prevent β-amyloid-mediated lysosomal destabilization in cultured neurons. In: Journal of Biological Chemistry. 2010 ; Vol. 285, No. 49. pp. 38543-38554.
@article{515b1a98ed9c4fbb91b0a623bbc91aa3,
title = "Endocannabinoids prevent β-amyloid-mediated lysosomal destabilization in cultured neurons",
abstract = "Neuronal cell loss underlies the pathological decline in cognition and memory associated with Alzheimer disease (AD). Recently, targeting the endocannabinoid system in AD has emerged as a promising new approach to treatment. Studies have identified neuroprotective roles for endocannabinoids against key pathological events in the AD brain, including cell death by apoptosis. Elucidation of the apoptotic pathway evoked by β-amyloid (Aβ) is thus important for the development of therapeutic strategies that can thwart Aβ toxicity and preserve cell viability. We have previously reported that lysosomal membrane permeabilization plays a distinct role in the apoptotic pathway initiated by Aβ. In the present study, we provide evidence that the endocannabinoid system can stabilize lysosomes against Aβ-induced permeabilization and in turn sustain cell survival. We report that endocannabinoids stabilize lysosomes by preventing the Aβ-induced up-regulation of the tumor suppressor protein, p53, and its interaction with the lysosomal membrane. We also provide evidence that intracellular cannabinoid type 1 receptors play a role in stabilizing lysosomes against Aβ toxicity and thus highlight the functionality of these receptors. Given the deleterious effect of lysosomal membrane permeabilization on cell viability, stabilization of lysosomes with endocannabinoids may represent a novel mechanism by which these lipid modulators confer neuroprotection.",
author = "Janis Noonan and Riffat Tanveer and Allan Klompas and Aoife Gowran and Joanne McKiernan and Campbell, {Veronica A.}",
year = "2010",
month = "12",
day = "3",
doi = "10.1074/jbc.M110.162040",
language = "English",
volume = "285",
pages = "38543--38554",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "49",

}

TY - JOUR

T1 - Endocannabinoids prevent β-amyloid-mediated lysosomal destabilization in cultured neurons

AU - Noonan, Janis

AU - Tanveer, Riffat

AU - Klompas, Allan

AU - Gowran, Aoife

AU - McKiernan, Joanne

AU - Campbell, Veronica A.

PY - 2010/12/3

Y1 - 2010/12/3

N2 - Neuronal cell loss underlies the pathological decline in cognition and memory associated with Alzheimer disease (AD). Recently, targeting the endocannabinoid system in AD has emerged as a promising new approach to treatment. Studies have identified neuroprotective roles for endocannabinoids against key pathological events in the AD brain, including cell death by apoptosis. Elucidation of the apoptotic pathway evoked by β-amyloid (Aβ) is thus important for the development of therapeutic strategies that can thwart Aβ toxicity and preserve cell viability. We have previously reported that lysosomal membrane permeabilization plays a distinct role in the apoptotic pathway initiated by Aβ. In the present study, we provide evidence that the endocannabinoid system can stabilize lysosomes against Aβ-induced permeabilization and in turn sustain cell survival. We report that endocannabinoids stabilize lysosomes by preventing the Aβ-induced up-regulation of the tumor suppressor protein, p53, and its interaction with the lysosomal membrane. We also provide evidence that intracellular cannabinoid type 1 receptors play a role in stabilizing lysosomes against Aβ toxicity and thus highlight the functionality of these receptors. Given the deleterious effect of lysosomal membrane permeabilization on cell viability, stabilization of lysosomes with endocannabinoids may represent a novel mechanism by which these lipid modulators confer neuroprotection.

AB - Neuronal cell loss underlies the pathological decline in cognition and memory associated with Alzheimer disease (AD). Recently, targeting the endocannabinoid system in AD has emerged as a promising new approach to treatment. Studies have identified neuroprotective roles for endocannabinoids against key pathological events in the AD brain, including cell death by apoptosis. Elucidation of the apoptotic pathway evoked by β-amyloid (Aβ) is thus important for the development of therapeutic strategies that can thwart Aβ toxicity and preserve cell viability. We have previously reported that lysosomal membrane permeabilization plays a distinct role in the apoptotic pathway initiated by Aβ. In the present study, we provide evidence that the endocannabinoid system can stabilize lysosomes against Aβ-induced permeabilization and in turn sustain cell survival. We report that endocannabinoids stabilize lysosomes by preventing the Aβ-induced up-regulation of the tumor suppressor protein, p53, and its interaction with the lysosomal membrane. We also provide evidence that intracellular cannabinoid type 1 receptors play a role in stabilizing lysosomes against Aβ toxicity and thus highlight the functionality of these receptors. Given the deleterious effect of lysosomal membrane permeabilization on cell viability, stabilization of lysosomes with endocannabinoids may represent a novel mechanism by which these lipid modulators confer neuroprotection.

UR - http://www.scopus.com/inward/record.url?scp=78649638441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649638441&partnerID=8YFLogxK

U2 - 10.1074/jbc.M110.162040

DO - 10.1074/jbc.M110.162040

M3 - Article

VL - 285

SP - 38543

EP - 38554

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 49

ER -